Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1075 | 973 | 1181 | 1121 | 1434 | - |
Fund Return | 7.53% | -2.66% | 18.1% | 3.87% | 7.48% | - |
Place in category | 1022 | 1357 | 1184 | 807 | 520 | - |
% in Category | 45 | 63 | 53 | 46 | 34 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1341630033 | 5.67B | 22.18 | 9.19 | - | ||
LU1344899445 | 5.67B | 18.17 | 3.85 | - | ||
Azioni Strategia Flessibile Class r | 4.9B | 5.71 | 1.45 | 3.24 | ||
Azioni Strategia Flessibile Class z | 4.9B | 6.48 | 2.33 | 4.10 | ||
Azioni Strategia Flessibile Class e | 4.9B | 6.49 | 2.34 | 4.10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund A Acc EUR | 160.17M | 12.55 | 4.13 | 5.59 | ||
European Growth Fund E Acc EUR | 21.05M | 11.84 | 3.35 | 4.80 | ||
European Growth Fund Y Acc EUR | 200.52M | 13.30 | 5.02 | 6.46 | ||
European Growth Fund Y DIST EUR | 65.13M | 13.33 | 5.02 | 6.47 | ||
European Growth Fund A DIST Eue | 6.63B | 12.54 | 4.13 | 5.59 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.51 | 750.9 | +4.03% | |
ASML Holding | NL0010273215 | 3.89 | 642.10 | +1.68% | |
AstraZeneca | GB0009895292 | 3.56 | 10,474.0 | +4.09% | |
Roche Holding Participation | CH0012032048 | 3.17 | 254.30 | +1.27% | |
Shell | GB00BP6MXD84 | 3.14 | 31.61 | +0.25% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review